Cours Parnell Pharmaceuticals Holdings Ltd Other OTC
Actions
PARNF
AU0000XINEU9
Produits pharmaceutiques
CA 2020 | 30 M 19,67 M 17,94 M | CA 2021 | 34,17 M 22,4 M 20,43 M | Capitalisation | 4,08 k 2,68 k 2,44 k |
---|---|---|---|---|---|
Résultat net 2020 | -15 M -9,83 M -8,97 M | Résultat net 2021 | -1 M -656 k -598 k | VE / CA 2020 | 2,18 x |
Dette nette 2020 | 56,16 M 36,82 M 33,58 M | Dette nette 2021 | 58,89 M 38,61 M 35,21 M | VE / CA 2021 | 1,72 x |
PER 2020 |
-0,56
x | PER 2021 |
-
| Employés | - |
Rendement 2020 * |
-
| Rendement 2021 |
-
| Flottant | 100% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Brad R. McCarthy
CEO | Chief Executive Officer | 48 | 01/02/10 |
Joe Rosentel
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/21 |
Pablo Lamberto
COO | Chief Operating Officer | - | - |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Jay B. Benear
BRD | Director/Board Member | - | - |
Doug Schillinger
BRD | Director/Board Member | 50 | - |
Eric Moore
BRD | Director/Board Member | - | 21/12/20 |
Varia. 1 janv. | Capi. | |
---|---|---|
-19,73% | 72,39 Md | |
-11,01% | 6,54 Md | |
+15,88% | 3,43 Md | |
-3,34% | 3,12 Md | |
+0,51% | 1,4 Md | |
-17,27% | 1,34 Md | |
-3,81% | 1,26 Md | |
-28,16% | 1,2 Md | |
-14,67% | 1,12 Md |